Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Teva
AstraZeneca
US Department of Justice
Mallinckrodt
Johnson and Johnson
UBS
Medtronic
Colorcon

Generated: February 18, 2019

DrugPatentWatch Database Preview

Heparin sodium - Generic Drug Details

« Back to Dashboard

What are the generic sources for heparin sodium and what is the scope of heparin sodium freedom to operate?

Heparin sodium is the generic ingredient in thirty-eight branded drugs marketed by Hospira, Intl Medication, Luitpold, Parke Davis, Smith And Nephew, Solopak, Abraxis Pharm, Akorn, Casi Pharms Inc, Chamberlin Parenterl, Dell Labs, Fresenius Kabi Usa, Gland Pharma Ltd, Hospira Inc, Lilly, Mylan Labs Ltd, Organon Usa Inc, Pfizer, Pharm Spec, Pharmacia And Upjohn, Sagent Pharms, Sandoz, Shenzhen Techdow, Sterinova Inc, Watson Labs, Watson Labs Inc, West-ward Pharms Int, Baxter Hlthcare, Mcgaw, B Braun, Pharma Serve Ny, and 3M, and is included in seventy-eight NDAs. Additional information is available in the individual branded drug profile pages.

There are seventy-seven drug master file entries for heparin sodium. Sixteen suppliers are listed for this compound.

Pharmacology for heparin sodium

US Patents and Regulatory Information for heparin sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER heparin sodium INJECTABLE;INJECTION 019952-001 Jul 20, 1992 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharm Spec HEPARIN SODIUM heparin sodium INJECTABLE;INJECTION 017780-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER heparin sodium INJECTABLE;INJECTION 018916-009 Jan 31, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
B Braun HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER heparin sodium INJECTABLE;INJECTION 019134-001 Mar 29, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Teva
Merck
Boehringer Ingelheim
Colorcon
Cipla
Chubb
Fuji
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.